What is the long-term trend for Indivior Pharmaceuticals, Inc. 's research and development expense?

Over 3 years (2022 to 2025), Indivior Pharmaceuticals, Inc. 's research and development expense has grown at a 9.4% compound annual growth rate (CAGR), from $74M to $97M.

Indivior Pharmaceuticals, Inc. INDV Research and development expense

Research and development expense at other companies

ON SemiconductorON

$144.3M-12.1%

TG TherapeuticsTGTX

$43.52M+1.1%

Corvex MOVE

$899K+12.4%

Monolithic Power SystemsMPWR

$100.57M+9.0%

Boston ScientificBSX

$516M+16.5%

Teradyne, Inc.TER

$135.56M+14.7%

Segments

By segment

See full

Reportable Segment$16M-27.3%

Other financials

Income statement

See full

Revenue$317.0M+19.2%

Gross profit$277.0M+24.8%

Operating income$137.0M+108%

Net income$89.0M+89.4%

EPS (diluted)$0.69+81.6%

Balance sheet

See full

Cash & equivalents$175.0M-53.0%

Total debt$509.0M+37.6%

Total equity-$144.0M+49.5%

Total assets$1.2B-12.9%

Cash flow

See full

Operating cash flow-$9.0M-112%

CapEx$20.0M+300%

Free cash flow-$29.0M-141%

Valuation

See full

Market cap$4.53B+213%

Profitability

See full

Gross margin81.3%+1.5pp

Operating margin25.8%+23.3pp

Net margin19.4%+18.9pp

FCF margin-14.9%—

Returns & leverage

See full

Current ratio0.9×0.0×

Where this comes from

Reported directly by Indivior Pharmaceuticals, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost.

The official record: Indivior Pharmaceuticals, Inc. ’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Indivior Pharmaceuticals, Inc. 's research and development expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Indivior Pharmaceuticals, Inc. 's research and development expense?: Indivior Pharmaceuticals, Inc. (INDV) reported research and development expense of $16M in Q1 2026.
How has Indivior Pharmaceuticals, Inc. 's research and development expense changed year-over-year?: Indivior Pharmaceuticals, Inc. 's research and development expense decreased by 27.3% year-over-year, from $22M to $16M.
What is the long-term trend for Indivior Pharmaceuticals, Inc. 's research and development expense?: Over 3 years (2022 to 2025), Indivior Pharmaceuticals, Inc. 's research and development expense has grown at a 9.4% compound annual growth rate (CAGR), from $74M to $97M.